Toxoplasmosis Testing Market - Global Outlook and Forecast 2022-2028

January 2022 | 67 pages | ID: T6977F6C7975EN
Market Monitor Global

Abstracts

The term toxoplasmosis refers to the infectious disease caused by the parasite Toxoplasma gondii. It may cause acute or chronic infection.

This report contains market size and forecasts of Toxoplasmosis Testing in Global, including the following market information:

Global Toxoplasmosis Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Toxoplasmosis Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Testing Equipment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Toxoplasmosis Testing include Abbott Laboratories, Affymetrix, Bio-Rad Laboratories, Beckman Coulter, Biomerica, Cepheid, Biotest and GenBio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Toxoplasmosis Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Toxoplasmosis Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Toxoplasmosis Testing Market Segment Percentages, by Type, 2021 (%)

• Testing Equipment
• Reagent Consumables

Global Toxoplasmosis Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Toxoplasmosis Testing Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Commercial Or Private Laboratories
• Physician Offices

Global Toxoplasmosis Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Toxoplasmosis Testing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Toxoplasmosis Testing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Toxoplasmosis Testing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• Affymetrix
• Bio-Rad Laboratories
• Beckman Coulter
• Biomerica
• Cepheid
• Biotest
• GenBio

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Toxoplasmosis Testing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Toxoplasmosis Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TOXOPLASMOSIS TESTING OVERALL MARKET SIZE

2.1 Global Toxoplasmosis Testing Market Size: 2021 VS 2028
2.2 Global Toxoplasmosis Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Toxoplasmosis Testing Players in Global Market
3.2 Top Global Toxoplasmosis Testing Companies Ranked by Revenue
3.3 Global Toxoplasmosis Testing Revenue by Companies
3.4 Top 3 and Top 5 Toxoplasmosis Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Toxoplasmosis Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Toxoplasmosis Testing Players in Global Market
  3.6.1 List of Global Tier 1 Toxoplasmosis Testing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Toxoplasmosis Testing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Toxoplasmosis Testing Market Size Markets, 2021 & 2028
  4.1.2 Testing Equipment
  4.1.3 Reagent Consumables
4.2 By Type - Global Toxoplasmosis Testing Revenue & Forecasts
  4.2.1 By Type - Global Toxoplasmosis Testing Revenue, 2017-2022
  4.2.2 By Type - Global Toxoplasmosis Testing Revenue, 2023-2028
  4.2.3 By Type - Global Toxoplasmosis Testing Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Toxoplasmosis Testing Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Commercial Or Private Laboratories
  5.1.4 Physician Offices
5.2 By Application - Global Toxoplasmosis Testing Revenue & Forecasts
  5.2.1 By Application - Global Toxoplasmosis Testing Revenue, 2017-2022
  5.2.2 By Application - Global Toxoplasmosis Testing Revenue, 2023-2028
  5.2.3 By Application - Global Toxoplasmosis Testing Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Toxoplasmosis Testing Market Size, 2021 & 2028
6.2 By Region - Global Toxoplasmosis Testing Revenue & Forecasts
  6.2.1 By Region - Global Toxoplasmosis Testing Revenue, 2017-2022
  6.2.2 By Region - Global Toxoplasmosis Testing Revenue, 2023-2028
  6.2.3 By Region - Global Toxoplasmosis Testing Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Toxoplasmosis Testing Revenue, 2017-2028
  6.3.2 US Toxoplasmosis Testing Market Size, 2017-2028
  6.3.3 Canada Toxoplasmosis Testing Market Size, 2017-2028
  6.3.4 Mexico Toxoplasmosis Testing Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Toxoplasmosis Testing Revenue, 2017-2028
  6.4.2 Germany Toxoplasmosis Testing Market Size, 2017-2028
  6.4.3 France Toxoplasmosis Testing Market Size, 2017-2028
  6.4.4 U.K. Toxoplasmosis Testing Market Size, 2017-2028
  6.4.5 Italy Toxoplasmosis Testing Market Size, 2017-2028
  6.4.6 Russia Toxoplasmosis Testing Market Size, 2017-2028
  6.4.7 Nordic Countries Toxoplasmosis Testing Market Size, 2017-2028
  6.4.8 Benelux Toxoplasmosis Testing Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Toxoplasmosis Testing Revenue, 2017-2028
  6.5.2 China Toxoplasmosis Testing Market Size, 2017-2028
  6.5.3 Japan Toxoplasmosis Testing Market Size, 2017-2028
  6.5.4 South Korea Toxoplasmosis Testing Market Size, 2017-2028
  6.5.5 Southeast Asia Toxoplasmosis Testing Market Size, 2017-2028
  6.5.6 India Toxoplasmosis Testing Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Toxoplasmosis Testing Revenue, 2017-2028
  6.6.2 Brazil Toxoplasmosis Testing Market Size, 2017-2028
  6.6.3 Argentina Toxoplasmosis Testing Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Toxoplasmosis Testing Revenue, 2017-2028
  6.7.2 Turkey Toxoplasmosis Testing Market Size, 2017-2028
  6.7.3 Israel Toxoplasmosis Testing Market Size, 2017-2028
  6.7.4 Saudi Arabia Toxoplasmosis Testing Market Size, 2017-2028
  6.7.5 UAE Toxoplasmosis Testing Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Toxoplasmosis Testing Major Product Offerings
  7.1.4 Abbott Laboratories Toxoplasmosis Testing Revenue in Global Market (2017-2022)
  7.1.5 Abbott Laboratories Key News
7.2 Affymetrix
  7.2.1 Affymetrix Corporate Summary
  7.2.2 Affymetrix Business Overview
  7.2.3 Affymetrix Toxoplasmosis Testing Major Product Offerings
  7.2.4 Affymetrix Toxoplasmosis Testing Revenue in Global Market (2017-2022)
  7.2.5 Affymetrix Key News
7.3 Bio-Rad Laboratories
  7.3.1 Bio-Rad Laboratories Corporate Summary
  7.3.2 Bio-Rad Laboratories Business Overview
  7.3.3 Bio-Rad Laboratories Toxoplasmosis Testing Major Product Offerings
  7.3.4 Bio-Rad Laboratories Toxoplasmosis Testing Revenue in Global Market (2017-2022)
  7.3.5 Bio-Rad Laboratories Key News
7.4 Beckman Coulter
  7.4.1 Beckman Coulter Corporate Summary
  7.4.2 Beckman Coulter Business Overview
  7.4.3 Beckman Coulter Toxoplasmosis Testing Major Product Offerings
  7.4.4 Beckman Coulter Toxoplasmosis Testing Revenue in Global Market (2017-2022)
  7.4.5 Beckman Coulter Key News
7.5 Biomerica
  7.5.1 Biomerica Corporate Summary
  7.5.2 Biomerica Business Overview
  7.5.3 Biomerica Toxoplasmosis Testing Major Product Offerings
  7.5.4 Biomerica Toxoplasmosis Testing Revenue in Global Market (2017-2022)
  7.5.5 Biomerica Key News
7.6 Cepheid
  7.6.1 Cepheid Corporate Summary
  7.6.2 Cepheid Business Overview
  7.6.3 Cepheid Toxoplasmosis Testing Major Product Offerings
  7.6.4 Cepheid Toxoplasmosis Testing Revenue in Global Market (2017-2022)
  7.6.5 Cepheid Key News
7.7 Biotest
  7.7.1 Biotest Corporate Summary
  7.7.2 Biotest Business Overview
  7.7.3 Biotest Toxoplasmosis Testing Major Product Offerings
  7.7.4 Biotest Toxoplasmosis Testing Revenue in Global Market (2017-2022)
  7.7.5 Biotest Key News
7.8 GenBio
  7.8.1 GenBio Corporate Summary
  7.8.2 GenBio Business Overview
  7.8.3 GenBio Toxoplasmosis Testing Major Product Offerings
  7.8.4 GenBio Toxoplasmosis Testing Revenue in Global Market (2017-2022)
  7.8.5 GenBio Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Toxoplasmosis Testing Market Opportunities & Trends in Global Market
Table 2. Toxoplasmosis Testing Market Drivers in Global Market
Table 3. Toxoplasmosis Testing Market Restraints in Global Market
Table 4. Key Players of Toxoplasmosis Testing in Global Market
Table 5. Top Toxoplasmosis Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Toxoplasmosis Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Toxoplasmosis Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Toxoplasmosis Testing Product Type
Table 9. List of Global Tier 1 Toxoplasmosis Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Toxoplasmosis Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Toxoplasmosis Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Toxoplasmosis Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Toxoplasmosis Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Toxoplasmosis Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Toxoplasmosis Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Toxoplasmosis Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Toxoplasmosis Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Toxoplasmosis Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Toxoplasmosis Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Toxoplasmosis Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Toxoplasmosis Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Toxoplasmosis Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Toxoplasmosis Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Toxoplasmosis Testing Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Toxoplasmosis Testing Product Offerings
Table 32. Abbott Laboratories Toxoplasmosis Testing Revenue (US$, Mn), (2017-2022)
Table 33. Affymetrix Corporate Summary
Table 34. Affymetrix Toxoplasmosis Testing Product Offerings
Table 35. Affymetrix Toxoplasmosis Testing Revenue (US$, Mn), (2017-2022)
Table 36. Bio-Rad Laboratories Corporate Summary
Table 37. Bio-Rad Laboratories Toxoplasmosis Testing Product Offerings
Table 38. Bio-Rad Laboratories Toxoplasmosis Testing Revenue (US$, Mn), (2017-2022)
Table 39. Beckman Coulter Corporate Summary
Table 40. Beckman Coulter Toxoplasmosis Testing Product Offerings
Table 41. Beckman Coulter Toxoplasmosis Testing Revenue (US$, Mn), (2017-2022)
Table 42. Biomerica Corporate Summary
Table 43. Biomerica Toxoplasmosis Testing Product Offerings
Table 44. Biomerica Toxoplasmosis Testing Revenue (US$, Mn), (2017-2022)
Table 45. Cepheid Corporate Summary
Table 46. Cepheid Toxoplasmosis Testing Product Offerings
Table 47. Cepheid Toxoplasmosis Testing Revenue (US$, Mn), (2017-2022)
Table 48. Biotest Corporate Summary
Table 49. Biotest Toxoplasmosis Testing Product Offerings
Table 50. Biotest Toxoplasmosis Testing Revenue (US$, Mn), (2017-2022)
Table 51. GenBio Corporate Summary
Table 52. GenBio Toxoplasmosis Testing Product Offerings
Table 53. GenBio Toxoplasmosis Testing Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Toxoplasmosis Testing Segment by Type in 2021
Figure 2. Toxoplasmosis Testing Segment by Application in 2021
Figure 3. Global Toxoplasmosis Testing Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Toxoplasmosis Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Toxoplasmosis Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Toxoplasmosis Testing Revenue in 2021
Figure 8. By Type - Global Toxoplasmosis Testing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Toxoplasmosis Testing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Toxoplasmosis Testing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Toxoplasmosis Testing Revenue Market Share, 2017-2028
Figure 12. US Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Toxoplasmosis Testing Revenue Market Share, 2017-2028
Figure 16. Germany Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Toxoplasmosis Testing Revenue Market Share, 2017-2028
Figure 24. China Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Toxoplasmosis Testing Revenue Market Share, 2017-2028
Figure 30. Brazil Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Toxoplasmosis Testing Revenue Market Share, 2017-2028
Figure 33. Turkey Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Toxoplasmosis Testing Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Toxoplasmosis Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Affymetrix Toxoplasmosis Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bio-Rad Laboratories Toxoplasmosis Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Beckman Coulter Toxoplasmosis Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Biomerica Toxoplasmosis Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Cepheid Toxoplasmosis Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Biotest Toxoplasmosis Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. GenBio Toxoplasmosis Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)